A detailed history of Brown Financial Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Brown Financial Advisors holds 2,474 shares of ABBV stock, worth $424,860. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,474
Previous 4,222 41.4%
Holding current value
$424,860
Previous $724 Million 32.53%
% of portfolio
0.2%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$163.84 - $199.33 $286,392 - $348,428
-1,748 Reduced 41.4%
2,474 $489 Million
Q2 2024

Aug 30, 2024

BUY
$154.79 - $180.76 $653,523 - $763,168
4,222 New
4,222 $724 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brown Financial Advisors Portfolio

Follow Brown Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Brown Financial Advisors with notifications on news.